Sponsor Pipeline

Inhatarget Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06896890 Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV… NSCLC (advanced Non-small Cell Lung Cancer) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Inhatarget Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free